No description available.

Bakterier som är resistenta mot antibiotika har de senaste åren blivit ett stort hot mot mänskligheten. Att utveckla nya antibiotikaläkemedel är väldigt tidskrävande samt kommer med en dyr prislapp. Det är några av anledningarna att forskare har inriktat sig på antimikrobiella peptider (AMPs) som ett alternativ till traditionella antibiotika. Dessa peptider finns i alla levande organismer och uppvisar en snabb och ospecifik mekanism. Vidare så är de mindre benägna att utveckla resistens hos bakterierna. Däremot så har dessa AMPar visat sig ha låg stabilitet och en del toxiska biverkningar. Olika typer av nanobärare kan användas för att överkomma dessa kommakortanden. Syftet med denna studie var att utveckla en optimerad nanobärare för AMPen AP114. Peptiden har blivit inkluderad i nanostrukturerade lipidbärare (NLC) samt liposomer. Dessa har producerats med smält emulsifieringsmetod och lösningsinjektion metoden. De fysikalkemiska karaktäristik hos olika blanka samt AP115 laddade nanoformuleringar har analyserats samt jämförts. Resultaten indikerade att liposomformuleringarna hade den lägsta partikelstorleken och storleksfördelning men en kontrollerad in vitro frisättning av peptiden över 48 timmar. Generellt, så indikerar de preliminära resultaten en potential nanoformulering för peptiden AP114. / In the past few years, bacterial resistance to antibiotics has posed a major threat to humankind. Development of substitutes for traditional antibiotics is a highly time consuming and expensive venture. For this reason, researchers are focusing on using antimicrobial peptides (AMP) as an alternate. These peptides are found in all living organisms and exhibit a fast and non-targeted mechanism of action. Besides, they are less susceptible to microbial resistance. However, these therapeutic peptides are not stable and have toxic side effects. To overcome these limitations, drug delivery systems have been explored. In this study, the aim was to develop an optimized drug delivery system for AP114. The peptide has been encapsulated in nanostructured lipid carriers (NLC) and liposomes, produced by melt emulsification method and solvent injection method, respectively. The physicochemical characterization of different blank and AP114 loaded nanoformulations were analyzed and compared. The results indicated the liposome samples to have the lowest particle size distribution and polydispersity, with a controlled in vitro release of the peptide over 48 hours. Overall, these preliminary findings suggest a promising potential for the formulation of a nanocarrier for AP114 peptide.

The designer proline-rich antimicrobial peptide (PrAMP) Chex1-Arg20 amide (ARV-1502) is active against Gram-negative and Gram-positive pathogens in differentmurine infection models when administered parenterally and possesses a wide therapeutic index. Here we studied the pharmacokinetics of ARV-1502 for the first time when administered intramuscularly or intravenously (IV) in Sprague Dawley rats and Beagle dogs. First, a specific and robust quantitation method relying on parallel reaction monitoring (PRM) using a high-resolution hybrid quadrupole-Orbitrap mass spectrometer coupled on-line to reversed-phase uHPLC was established and validated. The limit of detection was 2 ng/mL and the limit of quantitation was 4 ng/mL when spiked to pooled rat and dog plasma. When ARV-1502 was administered IV at doses of 75 and 250 μg/kg in dogs and rats, the plasma concentrations were 0.7 and 3.4μg/mL 2min post-administration, respectively. ARV-1502 plasma concentrations declined exponentially reaching levels between 2 and 4 ng/mL after 2 h. Intramuscular administration of 0.75 mg/kg in dogs and 2.5 mg/kg in rats resulted in a different pharmacokinetics profile. The plasma concentrations peaked at 15min post-injection at 1μg/mL (dogs) and 12μg/mL (rats) and decreased exponentially within 3 h to 4 and 16 ng/mL, respectively. The initial plasma concentrations of ARV-1502 and the decay timing afterwards indicated that the peptide circulated in the blood stream for several hours, at some point above the minimal inhibitory concentration against multidrug-resistant Enterobacteriaceae, with blood concentrations sufficient to suppress bacterial growth and to modulate the immune system.

No description available.

The Gram-negative bacterium Pseudomonas aeruginosa is a life-threatening nosocomial pathogen due to its generally low susceptibility toward antibiotics. Furthermore, many strains have acquired resistance mechanisms requiring new antimicrobials with novel mechanisms to enhance treatment options. Proline-rich antimicrobial peptides, such as the apidaecin analog Api137, are highly efficient against various Enterobacteriaceae infections in mice, but less active against P. aeruginosa in vitro. Here, we extended our recent work by optimizing lead peptides Api755 (gu-OIORPVYOPRPRPPHPRL-OH; gu = N,N,N′,N′-tetramethylguanidino, O = L-ornithine) and Api760 (gu-OWORPVYOPRPRPPHPRL-OH) by incorporation of Ile-Orn- and Trp-Orn-motifs, respectively. Api795 (gu-O(IO)2RPVYOPRPRPPHPRL-OH) and Api794 (gu-O(WO)3RPVYOPRPRPPHPRL-OH) were highly active against P. aeruginosa with minimal inhibitory concentrations of 8–16 and 8–32 μg/mL against Escherichia coli and Klebsiella pneumoniae. Assessed using a quartz crystal microbalance, these peptides inserted into a membrane layer and the surface activity increased gradually from Api137, over Api795, to Api794. This mode of action was confirmed by transmission electron microscopy indicating some membrane damage only at the high peptide concentrations. Api794 and Api795 were highly stable against serum proteases (half-life times >5 h) and non-hemolytic to human erythrocytes at peptide concentrations of 0.6 g/L. At this concentration, Api795 reduced the cell viability of HeLa cells only slightly, whereas the IC50 of Api794 was 0.23 ± 0.09 g/L. Confocal fluorescence microscopy revealed no colocalization of 5(6)-carboxyfluorescein-labeled Api794 or Api795 with the mitochondria, excluding interactions with the mitochondrial membrane. Interestingly, Api795 was localized in endosomes, whereas Api794 was present in endosomes and the cytosol. This was verified using flow cytometry showing a 50% higher uptake of Api794 in HeLa cells compared with Api795. The uptake was reduced for both peptides by 50 and 80%, respectively, after inhibiting endocytotic uptake with dynasore. In summary, Api794 and Api795 were highly active against P. aeruginosa in vitro. Both peptides passed across the bacterial membrane efficiently, most likely then disturbing the ribosome assembly, and resulting in further intracellular damage. Api795 with its IOIO-motif, which was particularly active and only slightly toxic in vitro, appears to represent a promising third generation lead compound for the development of novel antibiotics against P. aeruginosa.

Les antibiotiques sont fréquemment utilisés dans l’alimentation de la volaille afin de prévenir certaines maladies, dont l’entérite nécrotique, ce qui occasionne l’émergence de souches bactériennes résistantes aux antibiotiques. Une alternative prometteuse est l’utilisation de peptides antimicrobiens (AMPs) comme suppléments alimentaires, tels les AMPs provenant des produits laitiers. L’objectif du projet était de développer une méthode de production d’extraits peptidiques à partir de coproduits de la transformation alimentaire (babeurre, lactoferrine, isolat de protéines de pois), afin de tester si ces extraits peptidiques possédaient une activité antimicrobienne sur les pathogènes spécifiques aviaires suivants : Salmonella Enteritidis, Salmonella Typhimurium, Escherichia coli et Staphylococcus aureus. Les protéines ont été mises en suspension dans l’eau (5% p/p) et hydrolysées par la pepsine, 6 heures, pH de 2.5. Les peptides furent récupérés par ultrafiltration (< 10 kDa), puis fractionnés selon leur charge nette : totaux, cationiques, anioniques et non liés. L’effet antimicrobien a été évalué surmicroplaques, par la survie bactérienne en présence de concentrations croissantes d’extraits peptidiques. Les extraits cationiques de babeurre ont démontré une efficacité à une concentration inférieure ou égale à 5 mg/mL; perte de 3 log pour Escherichia coli O78 :H80. En comparaison, la lactoferrine cationique a été efficace à une concentration inférieure ou égale à 0.6 mg/mL; perte de 6 log pour E. coli O78 :H80. Les extraits peptidiques du pois ont démontré une efficacité faible. Cette méthode s’avère prometteuse pour le développement d’une alternative ou d’un complément pour la réduction de l’utilisation des antibiotiques dans l’alimentation de la volaille. / Antibiotics are frequently used in poultry feed in order to prevent certain diseases, including necrotic enteritis, which causes the emergence of bacterial strains resistant to antibiotics. A promising alternative is the use of antimicrobial peptides (AMPs) as dietary supplements, such as AMPs from dairy products. The objective of this project was to develop a production method for the extraction peptides, from co-produced food processing (buttermilk, lactoferrin, pea protein isolates). These peptides were tested for the detection of antimicrobial activity on the following specific poultry pathogens; Salmonella Enteritidis, Salmonella Typhimurium, Escherichia coli and Staphylococcus aureus. Proteins were suspended in water (5% w/w) and pepsin hydrolyzed by pepsin for 6 hours at pH 2.5. Peptides were recovered by ultrafiltration (< 10 kDa) and fractionated based on the basis of their ionic charges: total, cationic, anionic and unbound peptides, to specifically target the fractions with antimicrobial activities. Bacterial survival was measured in contact with different peptides concentrations. Cationic buttermilk extracts were effective at a concentration less or equal to 5 mg / mL; loss of 3 log for Escherichia coli O78: H80, compared with lactoferrin which was effective at a concentration less than or equal to 0.6 mg / mL; loss of 6 log for E. coli O78: H80. The peptide extracts from pea showed low efficiency. The use of antimicrobial peptides, from buttermilk, lactoferrin and peas, is promising for the development of an alternative or a complement to reduce antimicrobial use.

Proteínas e peptídeos ricos em glicina são encontrados em animais e plantas. Alguns apresentam atividade antimicrobiana. Como pouco se sabe sobre suas síntese, estrutura, relação estrutura-atividade e mecanismo de ação, tais tópicos foram estudados para os antimicrobianos cheferina I (Chef I) e/ou fragmentos da acantoscurrina (acanto). No que se refere à Chef I (67,9% de Gly, 28,6% de His, seis repetições do motivo GGH e uma Tyr), sintetizamos, purificamos, caracterizamos e testamos Chef I, os seus análogos truncados na(s) porção(ções) N- ou/e C-terminal (is) e os análogos amidados Chef la, Chef I (3-28)a e Chef I (6-28)a. Os três últimos e Chef I foram igualmente ativos frente a cepas de C. albicans (MIC: 12,5 &#181;M), mas não frente a cepas de C. tropicalis e S. cerevisiae. A amidação tornou o análogo Chef I (3-28)a mais ativo frente a tais cepas. Enquanto as atividades antifúngicas de Chef la e de seus análogos foram reduzidas pelo aumento da força iônica, elas foram aumentadas em presença de ZnCl2 5-10 &#181;M. A 62,5 &#181;M a Chef la foi letal para C. albicans MDM8. Ela foi pouco hemolítica em tampão fosfato contendo NaCl ou em tampão glicose fosfato isotônico (100 &#181;M: 18%). Análises por microscopia confocal e citometria de fluxo revelaram que Chef la marcada com carboxifluoresceína (FAM-Chef la) foi rapidamente internalizada nas células de C. albicans MDM8, um processo que não foi afetado pela força iônica do meio e se mostrou dependente de ATP e temperatura. Quanto aos fragmentos da acanto (proteína com 132 aminoácidos, 73% de Gly e 3 repetições de uma seqüência de 26 aminoácidos), estudamos a síntese em fase sólida dos fragmentos N- e C-terminais, acanto (1-22) e acanto (101-132) , respectivamente, e da porção repetitiva, acanto (23-48). Apesar de uma predição teórica não ter indicado alto potencial de agregação para a acanto, as sínteses foram problemáticas: a ocorrência de aminoacilações incompletas repetitivas a 60° C usando diferentes estratégias, resinas, reagentes acopladores, solventes e sais caotrópicos sugeriram a ocorrência de agregação das cadeias peptídicas em crescimento sobre as resinas O uso da resina CLEAR amida permitiu a obtenção do acanto (113-132). Tentativa de síntese convergente em fase sólida não foi bem sucedida. Espectros Raman das peptidil-resinas obtidas confirmaram a presença de estruturas em folha &#946; pregueada. Somente o uso combinado de resina CLEAR amida, 60°C, 20% DMSO/NMP, Fmoc-(Fmoc-Hmb)Gly-OH e LiCI permitiram a síntese total de acanto (101-132) . O uso da resina CLEAR ácida permitiu a síntese do fragmento acanto (23-48) e acanto (10-22) , esta última durante a tentativa de síntese do acanto (1-22) . Os rendimentos foram baixissimos e os espectros Raman das peptidil-resinas correspondentes também indicaram a formação de folhas &#946; pregueadas. Estes resultados indicaram que Chef I (3-28)a mimetiza Chef I, que Chef la é um fungicida potente com alvo intracelular, que a internalização do seu análogo marcado na célula de levedura ocorra via endocitose, que a Chef la tem potencial para agir como uma droga de uso tópico e que os fragmentos de acanto são \"difficult sequences\" típicas. / Proteins and peptides with high content of glycine have been found in animais and plants. Some of them display antimicrobial activity. As little is known about their chemical synthesis, structure, structure-activity relationship and mode of action, we studied such topics using shepherin I (Shep I) and fragments of acanthoscurrin (acantho) as targets. Concerning to Shep I (67.9% of Gly, 28.6% of His, six direct repeats of the motif GGH and one Tyr), we synthesized, purified, characterized and tested Shep I, its analogues truncated at the N- and/or C-terminal portions and the amidated analogues Shep la, Shep I (3-28)a and Shep I (6-28)a. The last three analogues and Shep I were equally active against C. albicans (MIC: 12.5 &#181;M) strains, but not against C. tropicalis and S. cerevisiae strains. Cterminal amidation made Shef I (3-28)a more active against those fungai strains. Anticandidal activities of Shep la and truncated analogues were inhibited in high ionic strength solutions, but enhanced at 10 &#181;M ZnCI (2 to 8-fold). At 62.5 &#181;M (5 MIC), Shep la killed C. albicans MDM8 in 30 mino It caused low hemolysis in phosphate buffered saline and isotonic glucose phosphate buffer (100 &#181;M: 18%). Confocal microscopy and flow cytometry analyses revealed that Shep I modified with carboxyfluorescein (FAM-Shep la) was rapidly internalized into C. albicans MDM8 cells, process not affected by ionic strength and showed to be energy and temperature-dependent. As to the fragments of acantho (a protein with 132 amino acids, 73% of Gly, and three repeats of 26 amino acids), we studied solid-phase syntheses of the N- and C-terminal portions, acantho (1-22) and acantho (101-132), respectively, and of the repetitive portion, acantho (23-48). A theoretical prediction did not indicate high aggregation potential for acantho, but solid-phase syntheses were troublesome: repetitive incomplete aminoacylations took place even at 60°C using different strategies, resins, coupling reagents, solvents and chaotropic salts, suggesting aggregation of the growing peptide chains. Change to CLEAR amide resin allowed obtaining acantho (113-132) . Attempt using convergent solid phase synthesis was not successful. Raman spectra of the growingpeptidyl-resins revealed pleated &#946;-sheet structures. Only the combination of CLEAR amide resin, 60°C, 20% DMSO/NMP, Fmoc-(Fmoc-Hmb)Gly-OH and LiCl allowed the total synthesis of acantho (101-132). The use of CLEAR acid resin also allowed obtaining the fragments acantho (23-48) and acantho (10-22), the last one during the attempt of the synthesis of acantho (1-22). The synthesis yields were extremely low and, again, the Raman spectra of the growing peptide-resins indicated the occurrence of pleated &#946;-sheet structures. Altogether, the results indicated that Shep l (3-28)a mimics the fungicidal activity of Shep l, Shep la is a potent anticandidacidal peptide that has an intracellular target, FAM Shep la may be internalized into the fungai cells via endocytosis, Shep la has the potential to act as a drug for topical use and acantho fragments are typical difficult sequences.

Proteínas e peptídeos ricos em glicina são encontrados em animais e plantas. Alguns apresentam atividade antimicrobiana. Como pouco se sabe sobre suas síntese, estrutura, relação estrutura-atividade e mecanismo de ação, tais tópicos foram estudados para os antimicrobianos cheferina I (Chef I) e/ou fragmentos da acantoscurrina (acanto). No que se refere à Chef I (67,9% de Gly, 28,6% de His, seis repetições do motivo GGH e uma Tyr), sintetizamos, purificamos, caracterizamos e testamos Chef I, os seus análogos truncados na(s) porção(ções) N- ou/e C-terminal (is) e os análogos amidados Chef la, Chef I (3-28)a e Chef I (6-28)a. Os três últimos e Chef I foram igualmente ativos frente a cepas de C. albicans (MIC: 12,5 &#181;M), mas não frente a cepas de C. tropicalis e S. cerevisiae. A amidação tornou o análogo Chef I (3-28)a mais ativo frente a tais cepas. Enquanto as atividades antifúngicas de Chef la e de seus análogos foram reduzidas pelo aumento da força iônica, elas foram aumentadas em presença de ZnCl2 5-10 &#181;M. A 62,5 &#181;M a Chef la foi letal para C. albicans MDM8. Ela foi pouco hemolítica em tampão fosfato contendo NaCl ou em tampão glicose fosfato isotônico (100 &#181;M: 18%). Análises por microscopia confocal e citometria de fluxo revelaram que Chef la marcada com carboxifluoresceína (FAM-Chef la) foi rapidamente internalizada nas células de C. albicans MDM8, um processo que não foi afetado pela força iônica do meio e se mostrou dependente de ATP e temperatura. Quanto aos fragmentos da acanto (proteína com 132 aminoácidos, 73% de Gly e 3 repetições de uma seqüência de 26 aminoácidos), estudamos a síntese em fase sólida dos fragmentos N- e C-terminais, acanto (1-22) e acanto (101-132) , respectivamente, e da porção repetitiva, acanto (23-48). Apesar de uma predição teórica não ter indicado alto potencial de agregação para a acanto, as sínteses foram problemáticas: a ocorrência de aminoacilações incompletas repetitivas a 60° C usando diferentes estratégias, resinas, reagentes acopladores, solventes e sais caotrópicos sugeriram a ocorrência de agregação das cadeias peptídicas em crescimento sobre as resinas O uso da resina CLEAR amida permitiu a obtenção do acanto (113-132). Tentativa de síntese convergente em fase sólida não foi bem sucedida. Espectros Raman das peptidil-resinas obtidas confirmaram a presença de estruturas em folha &#946; pregueada. Somente o uso combinado de resina CLEAR amida, 60°C, 20% DMSO/NMP, Fmoc-(Fmoc-Hmb)Gly-OH e LiCI permitiram a síntese total de acanto (101-132) . O uso da resina CLEAR ácida permitiu a síntese do fragmento acanto (23-48) e acanto (10-22) , esta última durante a tentativa de síntese do acanto (1-22) . Os rendimentos foram baixissimos e os espectros Raman das peptidil-resinas correspondentes também indicaram a formação de folhas &#946; pregueadas. Estes resultados indicaram que Chef I (3-28)a mimetiza Chef I, que Chef la é um fungicida potente com alvo intracelular, que a internalização do seu análogo marcado na célula de levedura ocorra via endocitose, que a Chef la tem potencial para agir como uma droga de uso tópico e que os fragmentos de acanto são \"difficult sequences\" típicas. / Proteins and peptides with high content of glycine have been found in animais and plants. Some of them display antimicrobial activity. As little is known about their chemical synthesis, structure, structure-activity relationship and mode of action, we studied such topics using shepherin I (Shep I) and fragments of acanthoscurrin (acantho) as targets. Concerning to Shep I (67.9% of Gly, 28.6% of His, six direct repeats of the motif GGH and one Tyr), we synthesized, purified, characterized and tested Shep I, its analogues truncated at the N- and/or C-terminal portions and the amidated analogues Shep la, Shep I (3-28)a and Shep I (6-28)a. The last three analogues and Shep I were equally active against C. albicans (MIC: 12.5 &#181;M) strains, but not against C. tropicalis and S. cerevisiae strains. Cterminal amidation made Shef I (3-28)a more active against those fungai strains. Anticandidal activities of Shep la and truncated analogues were inhibited in high ionic strength solutions, but enhanced at 10 &#181;M ZnCI (2 to 8-fold). At 62.5 &#181;M (5 MIC), Shep la killed C. albicans MDM8 in 30 mino It caused low hemolysis in phosphate buffered saline and isotonic glucose phosphate buffer (100 &#181;M: 18%). Confocal microscopy and flow cytometry analyses revealed that Shep I modified with carboxyfluorescein (FAM-Shep la) was rapidly internalized into C. albicans MDM8 cells, process not affected by ionic strength and showed to be energy and temperature-dependent. As to the fragments of acantho (a protein with 132 amino acids, 73% of Gly, and three repeats of 26 amino acids), we studied solid-phase syntheses of the N- and C-terminal portions, acantho (1-22) and acantho (101-132), respectively, and of the repetitive portion, acantho (23-48). A theoretical prediction did not indicate high aggregation potential for acantho, but solid-phase syntheses were troublesome: repetitive incomplete aminoacylations took place even at 60°C using different strategies, resins, coupling reagents, solvents and chaotropic salts, suggesting aggregation of the growing peptide chains. Change to CLEAR amide resin allowed obtaining acantho (113-132) . Attempt using convergent solid phase synthesis was not successful. Raman spectra of the growingpeptidyl-resins revealed pleated &#946;-sheet structures. Only the combination of CLEAR amide resin, 60°C, 20% DMSO/NMP, Fmoc-(Fmoc-Hmb)Gly-OH and LiCl allowed the total synthesis of acantho (101-132). The use of CLEAR acid resin also allowed obtaining the fragments acantho (23-48) and acantho (10-22), the last one during the attempt of the synthesis of acantho (1-22). The synthesis yields were extremely low and, again, the Raman spectra of the growing peptide-resins indicated the occurrence of pleated &#946;-sheet structures. Altogether, the results indicated that Shep l (3-28)a mimics the fungicidal activity of Shep l, Shep la is a potent anticandidacidal peptide that has an intracellular target, FAM Shep la may be internalized into the fungai cells via endocytosis, Shep la has the potential to act as a drug for topical use and acantho fragments are typical difficult sequences.

The Gram-negative bacterium Pseudomonas aeruginosa is a life-threatening nosocomial pathogen due to its generally low susceptibility toward antibiotics. Furthermore, many strains have acquired resistance mechanisms requiring new antimicrobials with novel mechanisms to enhance treatment options. Proline-rich antimicrobial peptides, such as the apidaecin analog Api137, are highly efficient against various Enterobacteriaceae infections in mice, but less active against P. aeruginosa in vitro. Here, we extended our recent work by optimizing lead peptides Api755 (gu-OIORPVYOPRPRPPHPRL-OH; gu = N,N,N′,N′-tetramethylguanidino, O = L-ornithine) and Api760 (gu-OWORPVYOPRPRPPHPRL-OH) by incorporation of Ile-Orn- and Trp-Orn-motifs, respectively. Api795 (gu-O(IO)2RPVYOPRPRPPHPRL-OH) and Api794 (gu-O(WO)3RPVYOPRPRPPHPRL-OH) were highly active against P. aeruginosa with minimal inhibitory concentrations of 8–16 and 8–32 μg/mL against Escherichia coli and Klebsiella pneumoniae. Assessed using a quartz crystal microbalance, these peptides inserted into a membrane layer and the surface activity increased gradually from Api137, over Api795, to Api794. This mode of action was confirmed by transmission electron microscopy indicating some membrane damage only at the high peptide concentrations. Api794 and Api795 were highly stable against serum proteases (half-life times >5 h) and non-hemolytic to human erythrocytes at peptide concentrations of 0.6 g/L. At this concentration, Api795 reduced the cell viability of HeLa cells only slightly, whereas the IC50 of Api794 was 0.23 ± 0.09 g/L. Confocal fluorescence microscopy revealed no colocalization of 5(6)-carboxyfluorescein-labeled Api794 or Api795 with the mitochondria, excluding interactions with the mitochondrial membrane. Interestingly, Api795 was localized in endosomes, whereas Api794 was present in endosomes and the cytosol. This was verified using flow cytometry showing a 50% higher uptake of Api794 in HeLa cells compared with Api795. The uptake was reduced for both peptides by 50 and 80%, respectively, after inhibiting endocytotic uptake with dynasore. In summary, Api794 and Api795 were highly active against P. aeruginosa in vitro. Both peptides passed across the bacterial membrane efficiently, most likely then disturbing the ribosome assembly, and resulting in further intracellular damage. Api795 with its IOIO-motif, which was particularly active and only slightly toxic in vitro, appears to represent a promising third generation lead compound for the development of novel antibiotics against P. aeruginosa.

Proline-rich antimicrobial peptides (PrAMPs) are promising candidates to treat bacterial infections. The designer peptide ARV-1502 exhibits strong antimicrobial effects against Enterobacteriaceae both in vitro and in vivo. Since the inhibitory effects of ARV-1502 reported for the 70 kDa heat-shock protein DnaK do not fully explain the antimicrobial activity of its 176 substituted analogs, we further studied their effect on the bacterial 70S ribosome of Escherichia coli, a known target of PrAMPs. ARV-1502 analogues, substituted in positions 3, 4, and 8 to 12 (underlined) of the binding motif D3KPRPYLPRP12 with aspartic acid, lysine, serine, phenylalanine or leucine, were tested in a competitive fluorescence polarization (FP) binding screening assay using 5(6)-carboxyfluoresceinlabeled (Cf-) ARV-1502 and the 70S ribosome isolated from E. coli BW25113. While their effect on ribosomal protein expression was studied for green fluorescent protein (GFP) in a cell-free expression system (in vitro translation), the importance of known PrAMP transporters SbmA and MdtM was investigated using E. coli BW25113 and the corresponding knockout mutants. The dissociation constant (Kd) of 201 16 nmol/L obtained for Cf-ARV-1502 suggests strong binding to the E. coli 70S ribosome. An inhibitory binding assay indicated that the binding site overlaps with those of other PrAMPs including Onc112 and pyrrhocoricin as well as the non-peptidic antibiotics erythromycin and chloramphenicol. All these drugs and drug candidates bind to the exit-tunnel of the 70S ribosome. Substitutions of the C-terminal fragment of the binding motif YLPRP reduced binding. At the same time, inhibition of GFP expression increased with net peptide charge. Interestingly, the MIC values of wild-type and DsbmA and DmdtM knockout mutants indicated that substitutions in the ribosomal binding motif altered also the bacterial uptake, which was generally improved by incorporation of hydrophobic residues. In conclusion, most substituted ARV-1502 analogs bound weaker to the 70S ribosome than ARV-1502 underlining the importance of the YLPRP binding motif. The weaker ribosomal binding correlated well with decreased antimicrobial activity in vitro. Substituted ARV-1502 analogs with a higher level of hydrophobicity or positive net charge improved the ribosome binding, inhibition of translation, and bacterial uptake.